Proteomics

Dataset Information

0

Protein arginine methyltransferase 5 (PRMT5) is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer


ABSTRACT: PRMT5 Co-IP mass spectrometry: Lysates of MCF-7 RB1-knockout cells were pulled down with a PRMT5 antibody or IgG control. The pulldowns were subjected to mass spectrometry analysis. QEX2_981005, QEX2_981006, QEX2_981007: DMSO, IgG QEX2_981008, QEX2_981009, QEX2_981010: DMSO, PRMT5 antibody QEX2_981011, QEX2_981012, QEX2_981013, GSK, IgG QEX2_981014, QEX2_981015, QEX2_981016, GSK, PRMT5 antibody SDMA PTM analysis: MCF-7 RB1-knockout cells were transfected with a PRMT5 siRNA or a control siRNA. Lysates were collected three days after transfection and subjected to mass spectrometry analysis. LUM1_1000791, LUM1_1000792, LUM1_1000793: control SiRNA LUM1_1000794, LUM1_1000795, LUM1_1000796: PRMT5 siRNA

INSTRUMENT(S): Orbitrap Fusion Lumos, Q Exactive HF

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Carlos L. Arteaga  

PROVIDER: MSV000092321 | MassIVE | Fri Jun 30 13:22:00 BST 2023

REPOSITORIES: MassIVE

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-01-12 | PXD046996 | Pride
2015-07-27 | GSE71009 | GEO
2019-10-30 | GSE138856 | GEO
2019-10-30 | GSE138885 | GEO
2022-08-05 | PXD003624 | Pride
2011-09-26 | E-GEOD-26564 | biostudies-arrayexpress
2015-04-10 | GSE67703 | GEO
2021-09-08 | PXD015242 | Pride
2021-08-12 | PXD027857 | Pride
2024-02-08 | GSE224896 | GEO